August 24, 2016 3:08 PM ET

Biotechnology

Company Overview of Syndax Pharmaceuticals, Inc.

Executive Profile

George W. Sledge Jr., M.D.

Independent Director, Member of Audit Committee and Member of Compensation Committee, Syndax Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 8 different industries.

See Board Relationships
64$189,349

Background

Dr. George W. Sledge, Jr., M.D., has been Professor and Chief of Medical Oncology at Stanford University Medical Center, as of January 2013. Dr. Sledge served as a Ballve-Lantero Professor of Oncology of Medicine and Pathology of Indiana University School of Medicine. He served as Co-Director of the breast cancer program at the Indiana University Cancer Center, where he was a Professor of Medicine and Pathology at the Indiana University Simon Cancer Center. Dr. Sledge ...

Corporate Headquarters

400 Totten Pond Road
Waltham, Massachusetts 02451

United States

Phone: 781-419-1400
Fax: 781-419-1420

Board Members Memberships

2014-Present
Independent Director, Member of Audit Committee and Member of Compensation Committee

Education

BA
University of Wisconsin - Madison
MD
Tulane University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$63,000
Total Calculated Compensation$189,349
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Syndax Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.